Business Context and Reporting Period
This Form 8-K was filed by Henry Schein, Inc. on June 21, 2018, reporting events that occurred on June 19, 2018. The filing addresses the status of a previously disclosed Reverse Morris Trust transaction involving the separation of the Company's animal health business.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate transactional events rather than financial performance data.
Material Changes
The primary material change reported is the termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) on June 19, 2018. This regulatory milestone removes a key condition precedent to the consummation of the planned transactions.
Outlook, Risks, and Transaction Details
Management confirmed that the Transactions, originally agreed upon on April 20, 2018, remain subject to customary conditions. The transaction structure includes:
- Contribution of the animal health business (Spinco Business) to a wholly-owned subsidiary, HS Spinco, Inc. (Spinco).
- Issuance of Spinco Common Stock to Henry Schein, Inc.
- Distribution of Spinco Common Stock to Henry Schein stockholders.
- Renaming of Spinco to Vets First Corp.
- Merger of HS Merger Sub, Inc. with Direct Vet Marketing, Inc. (d/b/a Vets First Choice), with Vets First Choice surviving as a wholly-owned subsidiary of Vets First Corp.
With the HSR waiting period terminated, the path to closing the transaction is clear, pending the satisfaction of any remaining customary conditions.
Investor Verification Checklist
- Confirm the exact closing date of the spin-off and merger once announced.
- Verify the exchange ratio for the distribution of Vets First Corp. shares to Henry Schein stockholders.
- Monitor for any remaining regulatory approvals or customary closing conditions that may still need to be satisfied.
- Review subsequent filings for the updated capital structure of Henry Schein, Inc. post-transaction.